This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignees: Cedars-Sinai Medical Center, Cedars-Sinai Medical, Prometheus Laboratories Inc.. Active years: 1999-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hermosa Beach, CA (US) (1999)
- Manhattan Beach, CA (US) (2010 - 2013)
Company Filing History:
5 out of 627 
1 out of 2 
1 out of 22 Years Active: 1999-2013
Title: Inventor Eric A. Vasiliauskas: Innovations in Gastrointestinal Health
Introduction: Eric A. Vasiliauskas, an innovative inventor based in Manhattan Beach, CA, has made significant contributions to the field of gastrointestinal health. With a total of six patents to his name, his work primarily focuses on advancing the understanding and treatment of inflammatory bowel diseases.
Latest Patents: Among Eric's latest patents is a groundbreaking invention that addresses long-term complications following Ileal Pouch-Anal Anastomosis (IPAA). This procedure is commonly performed on patients with ulcerative colitis, but post-operative pouchitis can occur. His patent presents methods for diagnosing and predicting susceptibility to pouchitis by detecting the presence of pANCA and Cbir1 Flagellin expression. Another of his notable patents provides methods for assessing Crohn's disease phenotypes through the detection of IgA anti-I2 antibodies, along with other biomarkers. This innovation allows for accurate diagnoses of various clinical subtypes of Crohn's disease, enhancing patient care and treatment strategies.
Career Highlights: Throughout his career, Eric has worked with esteemed institutions, including Cedars-Sinai Medical Center and Prometheus Laboratories Inc. His experience within these organizations has strengthened his expertise in medical research and patent development, significantly impacting the field of gastrointestinal health.
Collaborations: Eric A. Vasiliauskas has collaborated with renowned colleagues, including Stephan R. Targan and Scott E. Plevy. These partnerships have fostered the exchange of ideas and advancements in research, leading to the creation of his impactful patents.
Conclusion: Eric A. Vasiliauskas continues to demonstrate his commitment to innovation in the realm of gastrointestinal health. His inventive work has not only led to the development of valuable patents but also improved the diagnosis and treatment of complex gastrointestinal conditions. As he continues to collaborate and innovate, Eric's contributions will undoubtedly shape the future of medical research and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile